Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Molecular Templates, a biopharmaceutical company, has secured $2.5 million in financing from Sante Ventures. Proceeds from this financing will be used to continue product development and conduct human clinical trials.
Subscribe to our email newsletter
Eric Poma, CEO of Molecular Templates, said: “Cancer therapeutics is a crowded and competitive field. Molecular Templates’s platform technology is compelling because it allows us to rapidly screen for molecular markers that uniquely identify various types of cancer cells, and it allows us to combine into a single therapeutic compound both the specific cancer binding agents and a novel mechanism of action to kill targeted cells.”